SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " investor " 1,563 found 🔀 AI-powered Shuffle
The Ellisons add TikTok's U.S. business to their entertainment empire
TikTok has signed a deal to sell its U.S. operations to a group of investors led by Larry Ellison, the billionaire ally of Trump whose family media and entertainment empire just got bigger.
Market-savvy Treasury chief Scott Bessent emerges as unlikely MAGA warrior
Treasury Secretary Scott Bessent’s partisan comments are causing concern among investors and lawmakers, as he breaks with tradition and engages in combative rhetoric.
Six Flags Entertainment Corporation Securities Fraud Class Action Result of Undisclosed Financial Problems and 63% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
/PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial...
SpaceX Loses Starlink Satellite, This Space Stock Initiated Overweight
SpaceX loses contact with Starlink satellite in mishap. Intuitive Machines angles toward buy point. EchoStar rally continues.
Oracle stock jumps 5% as cloud provider joins investor group to run TikTok's U.S. business
The new joint venture will prevent TikTok from shutting down in the U.S. due to national security concerns.
Business Networking That Pays Off Takes A Commitment
Trying to create business contacts cold can be done — but it's tough. Creating connections through business networking is the easier way.
Youth Sports Was 2025’s Breakout M&A Theme. Here’s What’s Next
What had long been a fragmented, passion-driven corner of the sports economy became an active segment for investors and strategic acquirers.
TikTok agrees to deal to cede control of U.S. business to American investor group
The deal closes a long-running drama in which U.S. authorities have sought to compel ByteDance to divest.
TikTok reaches deal with investors on its US business
The deal comes more than a year after Congress passed a law that forced the Chinese company to divest its US operations or face a ban.
FedEx calls for more profit this year as this key business turns around
FedEx gives investors more reason to believe its overhaul is taking hold.
Bandai Namco sells Limbic Entertainment to "private investor"
Bandai Namco is selling Limbic Entertainment to "a private investor specializing in video games."
Famous Astrophysicist Defied The Odds To Become Science Star
Odds didn't favor a successful career in science for Neil deGrasse Tyson. But he had a key edge: parents who set no limits.
Bernard Arnault still isn't ready to talk about LVMH's real-life 'Succession' drama
LVMH CEO Bernard Arnault generally avoids succession talk, keeping investors guessing about future leadership at the luxury giant.
Americans Facing Soaring Health Insurance Costs May Get a Lifeline in 2026, Experts Say
By Amina Niasse and Ahmed Aboulenein NEW YORK/WASHINGTON, Dec 18 (Reuters) - Americans facing skyrocketing Obamacare health insurance premiums could still get a break from expanded government subsidies in 2026 through retroactive legislation and possibly a special enrollment period, investors,
Global Business Travel Group (GBTG): Reassessing Valuation After Recent Share Price Rebound and CWT Acquisition Progress
Global Business Travel Group (GBTG) has been quietly reshaping its business travel platform, and the stock’s recent mix of gains over the past month and weakness year to date has investors reassessing its trajectory. See our latest analysis for Global Business Travel Group. Despite the year to date share price return sitting in negative territory, the recent 1 month share price rebound and a solid three year total shareholder return suggest sentiment may be stabilising around Global Business...
Monumental Sports & Entertainment Announces Minority Investor Updates to Accelerate Growth and Innovation
/PRNewswire/ -- Monumental Sports & Entertainment ("MSE"), one of the nation's leading integrated sports, media, and entertainment companies, today announced...
Apple Seen Moving From AI Laggard To Leader In 2026
Morgan Stanley sees Apple becoming an AI leader in 2026, starting with a new Siri digital assistant. Apple stock is in a tight pattern.
Robinhood Expands Sports Betting Via Prediction Markets
Since the end of last year, 11 billion event contracts have been traded on Robinhood’s platform which allows investors to wager on sports, politics, and other categories.
Nick Gross joins Westbrook in leading $1B OKC entertainment district, soccer stadium
U.S. investor Nick Gross is joining Sacramento Kings G Russell Westbrook in backing a new entertainment district in Oklahoma City anchored by a new soccer stadium.
Pending vote could bring entertainment complex to Albany Mall
A tennis center proposed years ago in Albany is moving closer to reality after a local investor offered to donate property near the Albany Mall for the project.
Marcus Lemonis is retiring from Camping World
Before becoming host of the TV show “The Profit," he built the largest RV retailer and took investors for a bumpy ride.
SIX FLAGS ENTERTAINMENT CORPORATION (NYSE: FUN) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Six Flags Entertainment Corporation Investors of Upcoming Deadline
Six Flags Entertainment Shareholder Lawsuit Filed - Contact Bernstein Liebhard For More Information...
Looking at the Narrative for Golden Entertainment After Go Private Deal and Activist Pressure
Golden Entertainment's stock narrative has shifted as the market recalibrates around a go private deal that effectively anchors fair value at about $30.50 per share. While the fair value estimate and revenue growth outlook remain steady, the slightly higher discount rate signals a modestly increased required return that aligns with the deal driven risk profile. Investors can track these evolving assumptions and stay updated on the changing story behind the stock. Stay updated as the Fair...
Alexis Ohanian: ‘I can market excellence all day long’
The Reddit cofounder and sports investor shares why women’s sports are poised for massive growth—and how marketing excellence is driving the momentum.
Innovation Requires Striking The Right Balance
Innovation takes time. It requires a sustained commitment to trying — and often failing — to forge breakthroughs.
Broadcom's AI Business Is Growing Fast. Here's Why the Stock Is Tanking Anyway.
Broadcom on Thursday said its AI revenue will double in the current quarter, but shares slumped as investors focused on narrowing margins after a major run-up in the stock price.
Larry Ellison just lost $25 billion of his net worth in one day
Larry Ellison saw his wealth plunge after Oracle's earnings miss spooked investors and raised fresh questions about the company's massive AI spending.
Taking Stock of Elevance Health (ELV)’s Valuation After Digital Health Push and Board Refresh
Elevance Health (ELV) just paired a broader rollout of its AI powered Virtual Assistant with the appointment of veteran healthcare deal maker and governance expert Amy Schulman to its board, a combination investors should parse carefully. See our latest analysis for Elevance Health. Those digital health moves and the Schulman appointment are landing against a clear shift in sentiment, with the share price up 14.3 percent over the past month but a three year total shareholder return still...
How Investors May Respond To Elevance Health (ELV) Expanding AI Assistant Access And Adding Schulman To Board
Elevance Health recently expanded access to its AI-powered Virtual Assistant for about 22 million commercial members and announced that Amy Schulman, a senior healthcare executive and governance expert, will join its board and sit on the Audit and Finance Committees in January 2026. Together, these moves highlight Elevance Health’s push to blend digital-first member support with strengthened board oversight in healthcare innovation and regulatory strategy. We’ll now examine how the broader...
The New WHO Pandemic Treaty and Global Health Governance: Incorporating Common but Differentiated Responsibilities into PABS - Georgetown Journal of International Affairs
On May 20, 2025, the World Health Assembly unanimously adopted the World Health Organization (WHO) Pandemic Agreement, an international treaty designed to strengthen pandemic prevention, preparedness, and response. The product of three years of arduous negotiations, the treaty marks a new era of global cooperation in public health. However, core aspects of the agreement remain unresolved—notably the Pathogen Access and Benefit-Sharing (PABS) System, which is intended to ensure equitable access to pandemic-related materials and benefits. To support the successful implementation of the WHO Pandemic Agreement, the principle of “common but differentiated responsibilities” should be formally incorporated into the negotiating agenda of the PABS annex. Introduction For the first time, an international treaty has enshrined the principle of “One Health,” the compelling idea that the health of animals, humans, and the environment all contribute to pandemic risks. SARS (2003), H1N1 (2009–10), Ebola (2014–16), and COVID-19 all emerged through zoonotic spillover from animal hosts—respectively, civets, hogs, and bats. Together, they underscore the need for a coordinated, cross-sectoral approach. The Pandemic Agreement responds to this call, requiring state parties to acknowledge the ecological interplay and commit to a comprehensive “One Health” strategy. Specifically, Article 5 charges governments to address “the drivers of pandemics and the emergence and re-emergence of infectious disease at the human-animal-environment interface,” including wild animal markets, deforestation, and antibiotic overuse. Yet the effectiveness of this “One Health” vision depends equally on the free flow of scientific information and data among countries and institutions. Just as environmental and animal health factors have been neglected in past global frameworks, so too has data sharing been marginalized, despite its centrality to timely detection and response. The Pandemic Agreement takes an important step by requiring governments to enhance data collection and cooperate with the World Health Organization (WHO). However, these provisions will remain aspirational without a robust Pathogen Access and Benefit-Sharing (PABS) annex. The PABS system will determine whether countries and researchers can rapidly exchange pathogen samples and genetic data while ensuring equitable access to resulting research and development, including diagnostics, therapeutics, and vaccines. Without such mechanisms, the treaty’s promise to operationalize “One Health” and strengthen global preparedness will risk becoming largely symbolic, echoing earlier failures to translate shared principles into coordinated action. Equity Concerns When the 2025 Health Assembly adopted the Pandemic Agreement, it left the difficult question of access to pathogens and the sharing of resulting benefits to be addressed in a separate agreement. Negotiations on this separate agreement, PABS, are now underway in Geneva. Yet governments remain divided over fundamental questions of equity between the countries that primarily contribute to the system and those that primarily draw from it—and consequently benefit. For example, wildlife in countries bordering the equator is likely to produce PABS materials, but companies in Europe are likely to use them to develop lucrative products. The most likely contributor countries are likely to be those biodiverse countries around the equator, such as Brazil, the Democratic Republic of the Congo, and Indonesia, where the number of human-mammalian viral host interactions is large. Conversely, countries most likely to benefit from this material are those with the technology, investors, and infrastructure to capitalize on genomic data, such as the United States, EU member states, and Japan. This imbalance reflects a broader pattern seen in prior international frameworks. Now, as in the past, the wealthiest countries in the world (a useful heuristic is membership of the Organisation for Economic Co-operation and Development (OECD)) disproportionately benefit from systems in which pathogens and genomic sequencing data are contributed to a common source. Under the International Agreement on Plant Genetic Resources for Food and Agriculture (the “Plant Treaty” or “Seed Treaty”) and the Pandemic Influenza Preparedness (PIP) Framework, companies from Europe and North America disproportionately withdraw biological samples and data for development into lucrative medical products. Their governments and companies have both statutory and contractual claims to the products that those companies correspondingly produce. PABS appears poised to follow the same pattern. The text calls for strong language on access to pathogens and associated data, but the corresponding benefits that should flow to poorer countries are couched in equivocal or non-binding language. Common but Differentiated Responsibilities To address these inequities, the principle of “common but differentiated responsibilities” should be formally incorporated into the negotiating agenda of the PABS annex. Common but differentiated responsibilities are often a feature of climate change negotiations. The basic principle is that, even though all countries should reduce carbon emissions, governments that became rich and powerful through massive carbon emissions (e.g., France, the United Kingdom, the United States) should have a greater obligation to address the resulting crises. Applied to PABS, it would require that governments hosting and supporting companies developing lucrative products carry greater obligations toward the cost of running the PABS system; share benefits or final medical products; and transfer technology to help countries worldwide develop their own capacities to innovate and manufacture vaccines during an emergency. For example, an annex could mandate that any company based in an OECD country that withdraws PABS material would be obligated to donate the resulting diagnostics, therapeutics, or vaccines to the WHO during a public health emergency or pandemic. Questions remain about how robust those donations would be, but the principle is that they should deliver highly significant lifesaving benefits to be equitably shared. Theoretically, this approach mirrors the PIP Framework, in which companies withdrawing influenza samples are required to pay half of the operating costs. In practice, however, the framework has fallen short. The PIP Framework Secretariat has struggled to secure payments from companies, with companies often disagreeing over how much is owed. Additionally, without another pandemic influenza to test the strength of the agreement during a public health emergency, corporate compliance with sharing mechanisms remains unknown. Even if these limitations did not characterize the PIP Framework, partially paying for operating expenses does not address the inequity in access to genetic data and pathogen samples that left less developed countries last in line for COVID-19 vaccines (and, before them, H1N1). Common but differentiated responsibilities would go further, addressing governments’ legitimate grievances regarding information sharing. It would make withdrawals of PABS material and resulting products more transparent, building trust across the board. Enforcement and Enduring Success A key implication of this approach is that the governing mechanism of the PABS must have real enforcement authority. The WHO Pandemic Agreement delegates its core governance responsibilities to a Conference of the Parties (COP)—a governing body composed of one representative from each participating government, similar to those established under the UN Framework Convention on Climate Change and the WHO Framework Convention on Tobacco Control. The proposed WHO Pandemic Agreement COP is charged with oversight functions but ultimately possesses no real authority to compel a government to take any action it does not wish to take. The text does not give the COP the ability to, for example, sanction a party that does not comply with either textual obligations or PABS provisions. In other words, there are no effective mechanisms in place to ensure compliance. Perhaps just as significant, establishing a meaningful enforcement mechanism within the PABS system would strengthen the WHO’s credibility and its ability to ensure compliance across global health governance. By setting a precedent for accountability, such a mechanism could enhance the organization’s authority not only within the Pandemic Agreement but also in enforcing the revised International Health Regulations and other frameworks for public health emergencies. Conclusion The PABS annex can—and should—be different. It should establish clear responsibilities for funding as well as for sharing the diagnostics, therapeutics, and vaccines that result from contributions to the system. The system, in turn, must include a dedicated body empowered to hold governments and the corporations they sponsor accountable for their responsibilities before, during, and after pandemics. Doing so would restore trust in the broader agreement, which was eroded as commitments were repeatedly diluted while parties scrambled to meet their own self-imposed deadlines during the Pandemic Agreement negotiations. A robust PABS Annex would cement a grand social bargain. Wealthier countries and their corporations would gain unimpeded access to scientific information essential for developing and manufacturing lifesaving medical products. As such, they would stand to gain considerable economic benefit. Yet that privilege must be matched with responsibility. The grand bargain must include not only the right to innovate, but also the duty to ensure that innovation serves all. As medical products are developed and produced through collective contributions, every person must have equal access. All human beings deserve an equitable chance to survive—to save their own life, the lives of their families, and the well-being of their communities. … Sam Halabi, JD, MPhil, is the Bette Jacobs Endowed Professor at Georgetown University’s School of Health and the Director of the Center for Transformational Health Law at Georgetown Law. He serves as the co-lead for the WHO’s Working Group on Regulatory Consideration on AI and Health’s training workstream. He earned his JD from Harvard, his MPhil from Oxford, and undergraduate degrees from Kansas State University. Lawrence Gostin, LLD (Hon.), JD, BA, is University Distinguished Professor and Founding Director and Timothy and Linda O’Neill Professor of the O’Neill Institute for National and Global Health Law. He is the author of Global Health Security: A Blueprint for the Future (Harvard University Press, 2021); Global Health Law (Harvard University Press, 2014); Public Health Law: Power, Duty, Restraint (University of California Press, 3rd ed., 2016); Public Health Law and Ethics: A Reader (University of California Press, 3rd ed., 2018); Law and the Health System (Foundation Press, 2014); Principles of Mental Health Law & Practice (Oxford University Press, 2010). He also directs the WHO Collaborating Center at Georgetown University. Image Credit: United States Mission Geneva, CC BY 2.0, via Wikimedia Commons
University of Utah approves groundbreaking athletics plan to pursue private equity
While other schools like Clemson and Kentucky have spun off similar entities, Utah would be the first to include outside investors.
Political Shake-Up Hits Hedge-Fund Trade as Brazil Markets Swoon
As Brazil’s markets rallied, month after month, and global investors kept flooding in, the gains were big enough to overshadow the risks from a presidential election that’s still almost a year away.
AI doctors will be good at science but bad at business, and big talk with little action means even higher drugs prices: 10 healthcare predictions for 2026 from top investors
We hope 2026 is calmer after tariffs, public health chaos, and the cancellation of billions of research funding and health coverage support for millions.
European markets set for soft open as investors await Fed decision
European shares are expected to open mostly flat on Tuesday as global investors await the U.S. Federal Reserve's monetary policy update.
‘Only so long’ before Trump's tariff costs hit consumers, businesses warn
Corporate executives are telling investors that prices will rise as soon as January as pre-tariff inventory runs thin and holiday discounts disappear.
‘Only so long’ before Trump's tariff costs hit consumers, businesses warn
Corporate executives are telling investors that prices will rise as soon as January as pre-tariff inventory runs thin and holiday discounts disappear.
Investors lost at least $40 million on a Florida business that never had a client
His guilty plea says among his purchases with the fraudulently gained money were a 2011 54-foot Cruiser Yacht 540 Sports Coupe.
It's a winner-take-most economy
With fewer competitive participants, winning is harder, whether you're an investor, a consumer or a business.
Institutional investors own a significant stake of 40% in Seaport Entertainment Group Inc. (NYSE:SEG)
Key Insights Institutions' substantial holdings in Seaport Entertainment Group implies that they have significant...
Warren Buffett: Business titan and cover star
As the legendary investor prepares to step down, we looked back at his many appearances on Fortune’s cover.
MGM Resorts (MGM): Reassessing Valuation After Technical Breakout and Improving Global Entertainment Outlook
MGM Resorts International (MGM) just caught investors attention, jumping about 14% on the XETRA exchange as traders reacted to a clean technical breakout and improving sentiment around global entertainment demand. See our latest analysis for MGM Resorts International. Zooming out, that breakout sits on top of a steady grind higher, with a roughly 10% 1 month share price return and a modestly positive year to date move. However, the 1 year total shareholder return is still slightly negative,...
Hollywood's new money comes from Gulf investors
Foreign money raises questions about creative independence in U.S. entertainment.
AMC Entertainment Holdings, Inc. Transfers the Majority of its Equity Investment in Hycroft Mining Holding Corporation to Sprott Mining for a Net Consideration of $24.1 million
LEAWOOD, Kan., December 05, 2025--AMC Entertainment Holdings, Inc. (NYSE: AMC) ("AMC" or "the Company"), today announced that it has completed a transaction to transfer the majority of its equity investment in Hycroft Mining Holding Corporation (Nasdaq: HYMC) ("Hycroft") to Sprott Mining, a private Canadian corporation owned by one of the world’s leading gold and silver investors, Eric Sprott.
Boehly’s Eldridge and Arctos to Manage Sports and Media Retail Fund
Eldridge and Arctos are teaming up to give individual investors access to the typically exclusive world of sports and media, the latest effort from major money managers to jump into the space.
Brookfield Business Partners (NYSE:BBU): Exploring Valuation After Strong 3-Month Share Price Rally
Brookfield Business Partners (BBU) has been quietly rewarding patient investors, with the stock up around 6% this month and more than 30% over the past 3 months, despite posting a modest net loss. See our latest analysis for Brookfield Business Partners. Zooming out, Brookfield Business Partners’ recent 7 day share price return of nearly 8% builds on strong year to date momentum. Its 3 year total shareholder return above 100% shows that patient holders have been well compensated for the...
U.S. health care is broken. Here are 3 ways it's getting worse
One year after UnitedHealthcare's CEO was shot and killed, the crisis in U.S. health care is intensifying — even for the companies and investors who make money from it.
Why addressing deforestation is a strategic business priority
Companies, governments and investors increasingly see the business value of staying focused on responsible commodity production and sourcing.
Employer health plans lure investors
The Trump administration has across its two terms boosted alternative health plans as it dismantles the ACA..
Only social media platforms with 'real humanity' will survive, investor and Reddit cofounder Alexis Ohanian says
"At some point, more and more people are going to realize just how compromised much of social media is," Ohanian told Fortune.
How 2 issues in a week with the world's most popular plane spooked Airbus investors
Airbus has faced a challenging few days as it issued a software fix for its best-selling A320 family before confirming an issue with metal panels.
Gartner (IT) Slid on Weak Business Outlook
Scout Investments, Inc., an affiliate of Carillon Tower Advisers, recently released its third-quarter 2025 investor letter for “Carillon Scout Mid Cap Fund”. A copy of the letter can be downloaded here. The Russell Midcap Index posted positive returns in the quarter, fueled by strong corporate earnings, the continued momentum in artificial intelligence (AI) infrastructure, and the […]
Business entrepreneurs present pitches to public Friday
The gathering will not exactly be the long-running “Shark Tank” television show, yet business entrepreneurs, supporters or investors are invited to attend a presentation of business pitches during the High Country Accelerator Boat Launch Celebration...
High mortgage rates come back to bite real estate investors who bet on rising rents
Landlords built mini-empires of rental homes using billions of dollar's worth of once-obscure DSCR loans. For some, the cash isn't flowing as planned.
Alexis Ohanian Is Bullish on Women’s Sports
In March 2019, in response to the news that players from the U.S. women’s national soccer team had filed a gender-discrimination against their employer, the U.S. Soccer Federation, over pay inequality, Alexis Ohanian fired off a series of tweets. Ohanian, an investor and entrepreneur who co-founded Reddit and, since 2017, has been married to Serena…
Why AMC Entertainment Stock Got Mashed on Monday
Many an investor eye was on the holiday weekend, a crucial stretch for movie exhibitors.
Does Recent Business Model Shift Make DocuSign a Better Value for Investors in 2025?
Curious if DocuSign is trading at a bargain or if recent changes have made it less appealing? Let’s break down what has been happening and what it could mean for anyone eyeing the stock. DocuSign’s stock has experienced some volatility recently, climbing 5.2% in the last week, but still down 23.2% year-to-date and 13.6% over the past 12 months. Analyst discussion has focused on DocuSign’s evolving business model and strategic partnerships, both of which have been making headlines and...
Higher health costs force financial trade-offs: Investors 'worry about all these moving pieces,' top advisor says
Rising health premiums and expenses on top of already higher costs for everyday items are forcing people to make trade-offs in their budgets.
Truro City: Dawn Sports and Entertainment buy stake in National League club
Truro City's owners sell an 8.33% stake in the National League club to US investor Dawn Sports and Entertainment LLC.
3 Decisions That Will Define Politics This Week
Three major political decisions that could affect the markets are in focus this week. One is domestic; the other two are geopolitical. At home, investors are awaiting news of President Donald Trump’s choice for the next chair of the Federal Reserve. He has declined to give credence to a report by B
AI and science: Pioneering the 21st century
A new paradigm of AI-directed science is emerging to solve existential challenges, creating inelastic demand for mission-critical, high-performance computing, writes Tibor Schwartz, senior adviser at QIC.
HALPER SADEH LLC ENCOURAGES LIVE NATION ENTERTAINMENT, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Live Nation Entertainment, Inc....
Trump administration science assault slams major Bay Area economic engine, threatens ‘amazing innovations’
Investors and young scientists are pulling back from biotech, amid broader attacks on science under Trump, industry representatives said.
Trump administration science assault slams major Bay Area economic engine, threatens ‘amazing innovations’
Investors and young scientists are pulling back from biotech, amid broader attacks on science under Trump, industry representatives said.